Is This a Pan Raf Inhibitor?

The drug had been n over fog in over 225 adult patients that showed activity in bra b, six hundredmelonoma. The major driver mutation in that population is a wild type fusion where the type when rafton had riverse the dbratmes in the vamr aftetives can't be used. So there was a big unmat need. And now we had a drug hat tha, from a mechanistic point of view and pre clinicaldevisdno demonstrated, could be the right drug for that population.